---
title: "Abeona Therapeutics Insider Move Sparks Fresh Interest From Investors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291619466.md"
description: "Abeona Therapeutics director Leila Alland sold 11,000 shares worth $65,010 on July 2, 2026. TipRanks' AI Analyst Spark rates ABEO stock as Neutral, citing persistent operating losses and cash burn despite improving revenue and solid gross margins. Offsetting risks include manageable leverage, early commercial momentum, favorable payer coverage, and a low P/E. The stock shows a YTD price performance of 14.80%, with a current market cap of $344.8M and a technical sentiment signal of Buy."
datetime: "2026-07-03T02:04:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291619466.md)
  - [en](https://longbridge.com/en/news/291619466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291619466.md)
---

# Abeona Therapeutics Insider Move Sparks Fresh Interest From Investors

New insider activity at Abeona Therapeutics ( (ABEO) ) has taken place on July 2, 2026.

Director Leila Alland of Abeona Therapeutics has recently sold 11,000 shares of the company’s stock, in a transaction valued at $65,010. This insider sale provides investors with a clear view of ongoing share activity within Abeona’s leadership ranks and may factor into broader assessments of insider sentiment and trading patterns surrounding the biotech firm.

**Spark’s Take on ABEO Stock**

According to Spark, TipRanks’ AI Analyst, ABEO is a Neutral.

The score is held back primarily by persistent operating losses and heavy ongoing cash burn despite improving revenue and solid gross margins. Offsetting these risks are a relatively manageable leverage profile, early commercial momentum and favorable payer coverage discussed on the earnings call, and a low P/E that is tempered by concerns about earnings quality.

To see Spark’s full report on ABEO stock,  
click here.

**More about Abeona Therapeutics**

**YTD Price Performance:** 14.80%

**Average Trading Volume:** 1,154,481

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $344.8M

### Related Stocks

- [ABEO.US](https://longbridge.com/en/quote/ABEO.US.md)

## Related News & Research

- [Abeona Therapeutics Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/295818848.md)
- [Abeona Therapeutics Q2 net loss widens, misses analyst expectations](https://longbridge.com/en/news/295791975.md)
- [Abeona Therapeutics grants 10,800 restricted shares to new hires under Nasdaq inducement rule](https://longbridge.com/en/news/294685938.md)
- [ZoomInfo Targets Enterprise Growth With AI Credits, New Pricing and Cost Cuts](https://longbridge.com/en/news/295496375.md)
- [MindMaze Therapeutics completes organizational simplification, exits non-neurology legacy operations](https://longbridge.com/en/news/295359272.md)